Elanix Biotechnologies AG (FRA:ELN) Days Sales Outstanding : 370.70 (As of Dec. 2018)

View and export this data going back to . Start your Free Trial

What is Elanix Biotechnologies AG Days Sales Outstanding?

Elanix Biotechnologies AG's average Accounts Receivable for the six months ended in Dec. 2018 was €0.07 Mil. Elanix Biotechnologies AG's Revenue for the six months ended in Dec. 2018 was €0.03 Mil. Hence, Elanix Biotechnologies AG's Days Sales Outstanding for the six months ended in Dec. 2018 was 370.70.

The historical rank and industry rank for Elanix Biotechnologies AG's Days Sales Outstanding or its related term are showing as below:

FRA:ELN's Days Sales Outstanding is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 72.035
* Ranked among companies with meaningful Days Sales Outstanding only.

Elanix Biotechnologies AG's Days Sales Outstanding increased from Dec. 2017 (118.20) to Dec. 2018 (370.70).

Elanix Biotechnologies AG Days Sales Outstanding Historical Data

The historical data trend for Elanix Biotechnologies AG's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elanix Biotechnologies AG Days Sales Outstanding Chart

Elanix Biotechnologies AG Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Days Sales Outstanding

Get a 7-Day Free Trial

307.11

650.52

Elanix Biotechnologies AG Semi-Annual Data
	Dec08	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18
Days Sales Outstanding	Get a 7-Day Free Trial															-	4.68	118.20	885.13	370.70

Competitive Comparison of Elanix Biotechnologies AG's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Elanix Biotechnologies AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elanix Biotechnologies AG's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanix Biotechnologies AG's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Elanix Biotechnologies AG's Days Sales Outstanding falls into.

Elanix Biotechnologies AG Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Elanix Biotechnologies AG's Days Sales Outstanding for the fiscal year that ended in Dec. 2018 is calculated as

	Days Sales Outstanding (A: Dec. 2018 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2017 )	+	Accounts Receivable (A: Dec. 2018 ))	/	count )	/	Revenue (A: Dec. 2018 )	*	Days in Period
=	( (0.191	+	0.03)	/	2 )	/	0.062	*	365
=	0.1105					/	0.062	*	365
=	650.52

Elanix Biotechnologies AG's Days Sales Outstanding for the quarter that ended in Dec. 2018 is calculated as:

	Days Sales Outstanding (Q: Dec. 2018 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2018 )	+	Accounts Receivable (A: Dec. 2018 ))	/	count )	/	Revenue (A: Dec. 2018 )	*	Days in Period
=	( (0.1	+	0.03)	/	2 )	/	0.032	*	365 / 2
=	0.065					/	0.032	*	365 / 2
=	370.70

Elanix Biotechnologies AG (FRA:ELN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Elanix Biotechnologies AG Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Elanix Biotechnologies AG's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Elanix Biotechnologies AG (FRA:ELN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanix Biotechnologies AG (FRA:ELN) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Street-4, Georg-Glock, c/o HEUKING KÜHN LÜER WOJTEK, Dusseldorf, NW, DEU, 40474

Website

https://www.elanixbiotechnologies.ch

Elanix Biotechnologies AG is a tissue regeneration company. It develops and commercializes products for acute wound care, dermatological and gynecological applications as well as providing cell technology services. The company's operating segment include Regenerative Medicine and Cosmetic ointments. It generates maximum revenue from the Cosmetic ointments segment. Geographically, it derives a majority of revenue from Switzerland and also has a presence in the EU, and Taiwan.

Elanix Biotechnologies AG (FRA:ELN) Headlines

No Headlines